financetom
Business
financetom
/
Business
/
Cytokinetics Plans $550 Million Convertible Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cytokinetics Plans $550 Million Convertible Notes Offering
Sep 16, 2025 1:43 PM

04:18 PM EDT, 09/16/2025 (MT Newswires) -- Cytokinetics ( CYTK ) said late Tuesday that it intends to offer $550 million of convertible senior notes due 2031 in a private placement to institutional investors.

The company said it may also grant initial purchasers an option to buy up to an additional $82.5 million of the notes.

Shares were down over about 2% during after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Performed Line Products Q4 EPS Surges Over Year-Ago Period, Net sales Climb 15% Year-Over-Year
Performed Line Products Q4 EPS Surges Over Year-Ago Period, Net sales Climb 15% Year-Over-Year
Mar 13, 2025
05:10 PM EDT, 03/13/2025 (MT Newswires) -- Preformed Line Products ( PLPC ) late Thursday reported Q4 net income of $2.13 per diluted share compared with $1.29 a year earlier. Net sales for the quarter ended Dec. 31 was $167.1 million, compared with $145.6 million a year earlier. Analyst estimates for the networking equipment manufacturer were not available. Preformed Line...
Blink Charging Q4 Loss Narrows, Revenue Drops -- Shares Up After Hours
Blink Charging Q4 Loss Narrows, Revenue Drops -- Shares Up After Hours
Mar 13, 2025
05:10 PM EDT, 03/13/2025 (MT Newswires) -- Blink Charging ( BLNK ) reported an adjusted Q4 loss Thursday of $0.15 per diluted share, narrower than a loss of $0.28 a year earlier. Three analysts polled by FactSet expected a loss of $0.16. Revenue for the quarter ended Dec. 31 was $30.2 million, down from $42.7 million a year earlier. Analysts...
Sempra Insider Bought Shares Worth $350,024, According to a Recent SEC Filing
Sempra Insider Bought Shares Worth $350,024, According to a Recent SEC Filing
Mar 13, 2025
05:10 PM EDT, 03/13/2025 (MT Newswires) -- James C Yardley, Director, on March 12, 2025, executed a purchase for 5,019 shares in Sempra ( SRE ) for $350,024. Following the Form 4 filing with the SEC, Yardley has control over a total of 5,019 common shares of the company, with 5,019 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1032208/000106299325005403/xslF345X05/form4.xml ...
Alignment Healthcare Insider Sold Shares Worth $420,293, According to a Recent SEC Filing
Alignment Healthcare Insider Sold Shares Worth $420,293, According to a Recent SEC Filing
Mar 13, 2025
05:10 PM EDT, 03/13/2025 (MT Newswires) -- Dawn Christine Maroney, President, on March 12, 2025, sold 27,243 shares in Alignment Healthcare ( ALHC ) for $420,293. Following the Form 4 filing with the SEC, Maroney has control over a total of 2,276,732 common shares of the company, with 2,276,732 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1832466/000162828025012658/xslF345X05/wk-form4_1741899722.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved